Table of Contents
51 relations: Anabolic steroid, Anastrozole, Androgen, Anovulation, Antiandrogen, Antiestrogen withdrawal response, Antigonadotropin, Antiprogestogen, Aromatase inhibitor, Atrophic vaginitis, Biosynthesis, Breast atrophy, Breast cancer, Breast development, Clomifene, Depression (mood), Drug, Estradiol, Estrogen, Estrogen deprivation therapy, Estrogen receptor, Estrogen receptor alpha, Estrogen receptor beta, Estrogen synthesis inhibitor, Ethamoxytriphetol, Fulvestrant, Function (biology), Gonadotropin-releasing hormone modulator, Gynecomastia, Hot flash, Hypogonadism, Infertility, Libido, Masculinizing hormone therapy, Nonsteroidal, Osteoporosis, Ovulation induction, Progestogen, Raloxifene, Receptor antagonist, Selective estrogen receptor degrader, Selective estrogen receptor modulator, Sex-hormonal agent, Side effect, Steroid, Steroidogenesis inhibitor, Tamoxifen, Trans man, Triphenylethylene, Vaginal lubrication, ... Expand index (1 more) »
- Antiestrogens
Anabolic steroid
Anabolic steroids, also known as anabolic-androgenic steroids (AAS), are a class of drugs that are structurally related to testosterone, the main male sex hormone, and produce effects by binding to the androgen receptor (AR). Antiestrogen and anabolic steroid are hormonal antineoplastic drugs.
See Antiestrogen and Anabolic steroid
Anastrozole
Anastrozole, sold under the brand name Arimidex among others, is an antiestrogenic medication used in addition to other treatments for breast cancer. Antiestrogen and Anastrozole are hormonal antineoplastic drugs.
See Antiestrogen and Anastrozole
Androgen
An androgen (from Greek andr-, the stem of the word meaning "man") is any natural or synthetic steroid hormone that regulates the development and maintenance of male characteristics in vertebrates by binding to androgen receptors.
Anovulation
Anovulation is when the ovaries do not release an oocyte during a menstrual cycle.
See Antiestrogen and Anovulation
Antiandrogen
Antiandrogens, also known as androgen antagonists or testosterone blockers, are a class of drugs that prevent androgens like testosterone and dihydrotestosterone (DHT) from mediating their biological effects in the body. Antiestrogen and Antiandrogen are hormonal antineoplastic drugs.
See Antiestrogen and Antiandrogen
Antiestrogen withdrawal response
The antiestrogen withdrawal response is a paradoxical improvement in breast cancer caused by discontinuation of antiestrogen therapy for breast cancer. Antiestrogen and antiestrogen withdrawal response are antiestrogens.
See Antiestrogen and Antiestrogen withdrawal response
Antigonadotropin
An antigonadotropin is a drug which suppresses the activity and/or downstream effects of one or both of the gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).
See Antiestrogen and Antigonadotropin
Antiprogestogen
Antiprogestogens, or antiprogestins, also known as progesterone antagonists or progesterone blockers, are a class of drugs which prevent progestogens like progesterone from mediating their biological effects in the body.
See Antiestrogen and Antiprogestogen
Aromatase inhibitor
Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and in men, and gynecomastia in men. Antiestrogen and Aromatase inhibitor are hormonal antineoplastic drugs.
See Antiestrogen and Aromatase inhibitor
Atrophic vaginitis
Atrophic vaginitis is inflammation of the vagina as a result of tissue thinning due to low estrogen levels.
See Antiestrogen and Atrophic vaginitis
Biosynthesis
Biosynthesis, i.e., chemical synthesis occuring in biological contexts, is a term most often referring to multi-step, enzyme-catalyzed processes where chemical substances absorbed as nutrients (or previously converted through biosynthesis) serve as enzyme substrates, with conversion by the living organism either into simpler or more complex products.
See Antiestrogen and Biosynthesis
Breast atrophy
Breast atrophy is the normal or spontaneous atrophy or shrinkage of the breasts.
See Antiestrogen and Breast atrophy
Breast cancer
Breast cancer is a cancer that develops from breast tissue.
See Antiestrogen and Breast cancer
Breast development
Breast development, also known as mammogenesis, is a complex biological process in primates that takes place throughout a female's life.
See Antiestrogen and Breast development
Clomifene
Clomifene, also known as clomiphene, is a medication used to treat infertility in women who do not ovulate, including those with polycystic ovary syndrome.
See Antiestrogen and Clomifene
Depression (mood)
Depression is a mental state of low mood and aversion to activity.
See Antiestrogen and Depression (mood)
Drug
A drug is any chemical substance other than a nutrient or an essential dietary ingredient, which, when administered to a living organism, produces a biological effect.
Estradiol
Estradiol (E2), also spelled oestradiol, is an estrogen steroid hormone and the major female sex hormone.
See Antiestrogen and Estradiol
Estrogen
Estrogen (oestrogen; see spelling differences) is a category of sex hormone responsible for the development and regulation of the female reproductive system and secondary sex characteristics.
Estrogen deprivation therapy
Estrogen deprivation therapy, also known as endocrine therapy, is a form of hormone therapy that is used in the treatment of breast cancer.
See Antiestrogen and Estrogen deprivation therapy
Estrogen receptor
Estrogen receptors (ERs) are a group of proteins found inside cells.
See Antiestrogen and Estrogen receptor
Estrogen receptor alpha
Estrogen receptor alpha (ERα), also known as NR3A1 (nuclear receptor subfamily 3, group A, member 1), is one of two main types of estrogen receptor, a nuclear receptor (mainly found as a chromatin-binding protein) that is activated by the sex hormone estrogen.
See Antiestrogen and Estrogen receptor alpha
Estrogen receptor beta
Estrogen receptor beta (ERβ) also known as NR3A2 (nuclear receptor subfamily 3, group A, member 2) is one of two main types of estrogen receptor—a nuclear receptor which is activated by the sex hormone estrogen.
See Antiestrogen and Estrogen receptor beta
Estrogen synthesis inhibitor
An estrogen synthesis inhibitor is a type of drug which inhibits the enzymatic synthesis of estrogens, such as estradiol.
See Antiestrogen and Estrogen synthesis inhibitor
Ethamoxytriphetol
Ethamoxytriphetol (developmental code name MER-25) is a synthetic nonsteroidal antiestrogen that was studied clinically in the late 1950s and early 1960s but was never marketed. Antiestrogen and Ethamoxytriphetol are antiestrogens and hormonal antineoplastic drugs.
See Antiestrogen and Ethamoxytriphetol
Fulvestrant
Fulvestrant, sold under the brand name Faslodex among others, is an antiestrogenic medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with abemaciclib or palbociclib in women with disease progression after endocrine therapy. Antiestrogen and Fulvestrant are antiestrogens and hormonal antineoplastic drugs.
See Antiestrogen and Fulvestrant
Function (biology)
In evolutionary biology, function is the reason some object or process occurred in a system that evolved through natural selection.
See Antiestrogen and Function (biology)
Gonadotropin-releasing hormone modulator
A GnRH modulator, or GnRH receptor modulator, also known as an LHRH modulator or LHRH receptor modulator, is a type of medication which modulates the GnRH receptor, the biological target of the hypothalamic hormone gonadotropin-releasing hormone (GnRH; also known as luteinizing-releasing hormone, or LHRH). Antiestrogen and gonadotropin-releasing hormone modulator are hormonal antineoplastic drugs.
See Antiestrogen and Gonadotropin-releasing hormone modulator
Gynecomastia
Gynecomastia (also spelled gynaecomastia) is the abnormal non-cancerous enlargement of one or both breasts in males due to the growth of breast tissue as a result of a hormone imbalance between estrogens and androgens.
See Antiestrogen and Gynecomastia
Hot flash
Hot flashes (also known as hot flushes) are a form of flushing, often caused by the changing hormone levels that are characteristic of menopause.
See Antiestrogen and Hot flash
Hypogonadism
Hypogonadism means diminished functional activity of the gonads—the testicles or the ovaries—that may result in diminished production of sex hormones.
See Antiestrogen and Hypogonadism
Infertility
Infertility is the inability of an animal or plant to reproduce by natural means.
See Antiestrogen and Infertility
Libido
In psychology, libido (from the Latin, 'desire') is psychic drive or energy, usually conceived as sexual in nature, but sometimes conceived as including other forms of desire.
Masculinizing hormone therapy
Masculinizing hormone therapy, also known as transmasculine hormone therapy or female-to-male (or FTM) hormone therapy, is a form of hormone therapy and gender affirming therapy which is used to change the secondary sexual characteristics of transgender people from feminine or androgynous to masculine.
See Antiestrogen and Masculinizing hormone therapy
Nonsteroidal
A nonsteroidal compound is a drug that is not a steroid nor a steroid derivative.
See Antiestrogen and Nonsteroidal
Osteoporosis
Osteoporosis is a systemic skeletal disorder characterized by low bone mass, micro-architectural deterioration of bone tissue leading to more porous bone, and consequent increase in fracture risk.
See Antiestrogen and Osteoporosis
Ovulation induction
Ovulation induction is the stimulation of ovulation by medication.
See Antiestrogen and Ovulation induction
Progestogen
Progestogens, also sometimes written progestins, progestagens or gestagens, are a class of natural or synthetic steroid hormones that bind to and activate the progesterone receptors (PR).
See Antiestrogen and Progestogen
Raloxifene
Raloxifene, sold under the brand name Evista among others, is a medication used to prevent and treat osteoporosis in postmenopausal women and those on glucocorticoids.
See Antiestrogen and Raloxifene
Receptor antagonist
A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist.
See Antiestrogen and Receptor antagonist
Selective estrogen receptor degrader
A selective estrogen receptor degrader or downregulator (SERD) is a type of drug which binds to the estrogen receptor (ER) and, in the process of doing so, causes the ER to be degraded and thus downregulated. Antiestrogen and selective estrogen receptor degrader are antiestrogens and hormonal antineoplastic drugs.
See Antiestrogen and Selective estrogen receptor degrader
Selective estrogen receptor modulator
Selective estrogen receptor modulators (SERMs), also known as estrogen receptor agonist/antagonists (ERAAs), are a class of drugs that act on estrogen receptors (ER). Antiestrogen and Selective estrogen receptor modulator are hormonal antineoplastic drugs.
See Antiestrogen and Selective estrogen receptor modulator
Sex-hormonal agent
A sex-hormonal agent, also known as a sex-hormone receptor modulator, is a type of hormonal agent which specifically modulates the effects of sex hormones and of their biological targets, the sex hormone receptors.
See Antiestrogen and Sex-hormonal agent
Side effect
In medicine, a side effect is an effect, whether therapeutic or adverse, that is unintended; although the term is predominantly employed to describe adverse effects, it can also apply to beneficial, but unintended, consequences of the use of a drug.
See Antiestrogen and Side effect
Steroid
A steroid is an organic compound with four fused rings (designated A, B, C, and D) arranged in a specific molecular configuration.
Steroidogenesis inhibitor
A steroidogenesis inhibitor, also known as a steroid biosynthesis inhibitor, is a type of drug which inhibits one or more of the enzymes that are involved in the process of steroidogenesis, the biosynthesis of endogenous steroids and steroid hormones.
See Antiestrogen and Steroidogenesis inhibitor
Tamoxifen
Tamoxifen, sold under the brand name Nolvadex among others, is a selective estrogen receptor modulator used to prevent breast cancer in women and men. Antiestrogen and Tamoxifen are hormonal antineoplastic drugs.
See Antiestrogen and Tamoxifen
Trans man
A trans man (short for transgender man) is a man who was assigned female at birth.
See Antiestrogen and Trans man
Triphenylethylene
Triphenylethylene (TPE) is a simple aromatic hydrocarbon that possesses weak estrogenic activity.
See Antiestrogen and Triphenylethylene
Vaginal lubrication
Vaginal lubrication is a naturally produced fluid that lubricates the vagina.
See Antiestrogen and Vaginal lubrication
Woman
A woman is an adult female human.
See also
Antiestrogens
- (R,R)-Tetrahydrochrysene
- 4'-Hydroxynorendoxifen
- 7β-Hydroxy-DHEA
- Abiraterone acetate
- Acefluranol
- Amphenone B
- Antiestrogen
- Antiestrogen withdrawal response
- Baicalein
- Brilanestrant
- CCL18
- Clometerone
- Cytestrol acetate
- Danazol
- Dimepregnen
- ERX-11
- Elacestrant
- Epitiostanol
- Etacstil
- Ethamoxytriphetol
- Fulvestrant
- Gestrinone
- Glyceollin
- Glyceollin I
- Glyceollin III
- ICI-164384
- MIBE
- Mepitiostane
- Methylepitiostanol
- Methylpiperidinopyrazole
- Minamestane
- PHTPP
- Plomestane
- Prochloraz
- RU-16117
- Selective estrogen receptor degrader
- Selective estrogen receptor degraders
- TAS-108
- Trilostane
- ZB716
References
Also known as Anti-estrogen, Anti-estrogenic, Anti-estrogens, Antiestrogenic, Antiestrogens, ER antagonist, ER antagonists, ER blocker, ER blockers, Estradiol antagonist, Estradiol antagonists, Estradiol blocker, Estradiol blockers, Estradiol receptor antagonist, Estradiol receptor antagonists, Estradiol receptor blocker, Estradiol receptor blockers, Estrogen antagonist, Estrogen antagonists, Estrogen blocker, Estrogen blockers, Estrogen receptor antagonist, Estrogen receptor antagonists, Estrogen receptor blocker, Estrogen receptor blockers, Oestrogen blocker, Oestrogen blockers.